Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.
about
Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the FieldPersistence of microbial contamination on transvaginal ultrasound probes despite low-level disinfection procedureThe role of MRI in prostate cancer diagnosis and management.Infection-Related Hospital Admissions After Prostate Biopsy in United States Men.Transperineal vs. transrectal biopsy in MRI targeting.Fluoroquinolone-resistant Escherichia coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy - possible shift in biopsy prophylaxis.Radical prostatectomy in the presence of ongoing refractory ESBL Escherichia coli bacterial prostatitis.Oral antibiotics in trans-rectal prostate biopsy and its efficacy to reduce infectious complications: Systematic review.Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy.Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study.Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during the perioperative period of ultrasound-guided transrectal prostate biopsy.Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?Optimization of prostate biopsy: review of technique and complications.Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis.Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use.The emerging threat of multidrug-resistant Gram-negative bacteria in urology.The global burden of major infectious complications following prostate biopsy.Significant impact of transperineal template biopsy of the prostate at a single tertiary institution.The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.Optimizing safety and accuracy of prostate biopsy.Association between pre-biopsy white blood cell count and prostate biopsy - related sepsis."Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: A prospective randomized studyDisinfection of transvaginal ultrasound probes in a clinical setting: comparative performance of automated and manual reprocessing methods.Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.Clinical and microbiological determinants of infection after transrectal prostate biopsy.Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.Pokes, pathogens, and primum non nocere: prudent prophylaxis protocols for prostate biopsy.Implications of the new AUA guidelines on prostate cancer detection in the U.S.Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.Assessment of cone beam CT registration for prostate radiation therapy: fiducial marker and soft tissue methods.Infectious complications following transrectal ultrasound-guided prostate biopsy: a Canadian tertiary cancer center experience.Editorial comment to Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacterial and treatment patterns from a 4-year prospective study.
P2860
Q26786281-86075513-909F-4BFB-B2C1-703C2DBD4908Q28541816-4A8D45CD-9141-448B-BB9B-96EF6115F6AEQ30245245-0E057532-525E-4C20-8151-E17257566A99Q33629055-0B8841C7-B9DB-4459-A49D-EAE28C94D13CQ33890171-96A5B1CF-0B2E-4EC4-8669-314D57CEAB94Q33904076-DE0DE0BA-BD19-4141-A6A2-B8F66CEDBD0FQ34365290-76349E58-A3DD-47D9-9AEB-E09E50F97FB3Q34500632-02A37A5A-A85B-4360-9EA3-32B221DF9050Q36195454-13902868-2373-401B-89D3-4698E4BF8C03Q36259927-2059DA27-8825-4C41-A868-CA57038828A2Q36449942-5AFDA984-4652-434E-B5CB-6D7B0537A9D9Q37280666-471F6B6A-6C51-4498-A694-A8904EC46CA3Q37329659-CFC56A74-1DF0-4A66-A1B6-FDF574BF074CQ38194656-ACDE2BAC-5957-4D53-872B-82645CACE042Q38203986-A22A08FE-4B0C-4475-A3B9-7C5ED596D543Q38221132-6A11DD92-F79A-4163-BD86-260E1C3B25B2Q38306530-83A7DB15-5592-4750-825D-2BD127B467BBQ38579512-6666C917-1E1F-4D72-8B13-A6D551A71EA8Q38662109-785A358B-25E2-4B95-9047-6B328150BC67Q38675981-433155CD-D4B7-45FB-923A-2815A44F0316Q38680898-6A0C94AF-C9F6-4BCC-9053-640F008DB523Q38841864-BFACC5E0-8A3A-4230-AA81-2CFEC6C4B358Q39921860-74FDE8A3-6B5C-4E7F-97EF-22897E7E9F0DQ40040822-F233BA4F-CFDA-4BFE-A83D-0D423A87CAA2Q40115001-7962F877-DC7B-4685-87FF-7594BE787F59Q40168017-073A764F-0C91-42B7-ADA2-23D7C02FA4BFQ40409270-D761EDCE-7B43-4F4D-8B74-2980FDD6539DQ40478073-C2033598-21B8-4EF2-B422-31D002C4D4C9Q40586803-3D8B0318-7BF7-46CC-8675-BD0E3E55C39EQ41169926-A36C5905-B5BC-49CE-9B92-AC5BEE15C553Q41172930-0D21316E-0535-4D0D-94B7-C2302CB79182Q41595384-117E18B5-7AAB-47A2-B558-2FD9F6330818Q42242522-07721D3D-E6B5-42B7-83BD-AB7842839B59Q42252341-E05DA77D-378A-4BC5-A71A-8320986E86CFQ45122930-E5106184-F9CD-4AF1-B699-A60D32872287Q46619813-C6B8D3FF-937E-4806-8780-0316481050E5Q53087894-D023F016-47C9-4A7C-99EE-8EA6DBC39FDEQ53147440-860A1AD7-49BE-4102-8C0F-D7FE5156CEB7Q53608467-016D0911-69B0-45E7-A507-86F7A245E2AFQ54306438-F13D2EBB-0919-4B98-8303-DDE1E9C0E353
P2860
Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Infectious complications follo ...... ug-resistant Escherichia coli.
@en
type
label
Infectious complications follo ...... ug-resistant Escherichia coli.
@en
prefLabel
Infectious complications follo ...... ug-resistant Escherichia coli.
@en
P2093
P2860
P50
P356
P1476
Infectious complications follo ...... ug-resistant Escherichia coli.
@en
P2093
Joshua T Freeman
Lucinda K Barrett
Paul Hadway
P2860
P304
P356
10.1093/CID/CIT193
P407
P577
2013-03-26T00:00:00Z